Atlas Trials

Safety and Efficiency of γδ T Cell Against Breast Cancer

Clinical trial NCT03183206 · COMPLETED

Trial details

NCT number
NCT03183206
Sponsor
Fuda Cancer Hospital, Guangzhou
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2017-06-15
Primary completion
2018-06-15
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.